Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Monarca

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scientific Reports|September 11, 2019
Silver ions promote blebs growth in U251 glioblastoma cell by activating nonselective cationic currentsFrancesco Ragonese, Lorenzo Monarca, Federica Bastioli, et al.
Pharmaceutics|April 26, 2025
Silver Nanoparticles Decorated UiO-66-NH<sub>2</sub> Metal-Organic Framework for Combination Therapy in Cancer TreatmentFrancesco Ragonese, Letizia Trovarelli, Lorenzo Monarca, et al.
Pharmaceutics|March 28, 2024
Synthesis and Characterization of ZIF-90 Nanoparticles as Potential Brain Cancer TherapyLorenzo Monarca, Francesco Ragonese, Paola Sabbatini, et al.
International Journal of Molecular Sciences|June 27, 2024
Electrophysiological Impact of SARS-CoV-2 Envelope Protein in U251 Human Glioblastoma Cells: Possible Implications in Gliomagenesis?Lorenzo Monarca, Francesco Ragonese, Andrea Biagini, et al.
Nanomaterials (Basel, Switzerland)|October 27, 2018
Probing Internalization Effects and Biocompatibility of Ultrasmall Zirconium Metal-Organic Frameworks UiO-66 NP in U251 Glioblastoma Cancer CellsCataldo Arcuri, Lorenzo Monarca, Francesco Ragonese, et al.
Fertility and Sterility|January 25, 2021
Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesisFrancesco Ragonese, Lorenzo Monarca, Antonella De Luca, et al.
Current Pharmaceutical Design|March 17, 2020
New Insights on KCa3.1 Channel ModulationGiuseppe Manfroni, Francesco Ragonese, Lorenzo Monarca, et al.
Current Pharmaceutical Design|April 3, 2020
Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma TherapyLamberto Dionigi, Francesco Ragonese, Lorenzo Monarca, et al.
Frontiers in Physiology|January 24, 2022
LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma CellsConcetta Caglioti, Federico Palazzetti, Lorenzo Monarca, et al.
Nutrients|December 20, 2018
Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral BioavailabilityRoberto Spogli, Maria Bastianini, Francesco Ragonese, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|September 11, 2019
Silver ions promote blebs growth in U251 glioblastoma cell by activating nonselective cationic currentsFrancesco Ragonese, Lorenzo Monarca, Federica Bastioli, et al.
Pharmaceutics|April 26, 2025
Silver Nanoparticles Decorated UiO-66-NH<sub>2</sub> Metal-Organic Framework for Combination Therapy in Cancer TreatmentFrancesco Ragonese, Letizia Trovarelli, Lorenzo Monarca, et al.
Pharmaceutics|March 28, 2024
Synthesis and Characterization of ZIF-90 Nanoparticles as Potential Brain Cancer TherapyLorenzo Monarca, Francesco Ragonese, Paola Sabbatini, et al.
International Journal of Molecular Sciences|June 27, 2024
Electrophysiological Impact of SARS-CoV-2 Envelope Protein in U251 Human Glioblastoma Cells: Possible Implications in Gliomagenesis?Lorenzo Monarca, Francesco Ragonese, Andrea Biagini, et al.
Nanomaterials (Basel, Switzerland)|October 27, 2018
Probing Internalization Effects and Biocompatibility of Ultrasmall Zirconium Metal-Organic Frameworks UiO-66 NP in U251 Glioblastoma Cancer CellsCataldo Arcuri, Lorenzo Monarca, Francesco Ragonese, et al.
Fertility and Sterility|January 25, 2021
Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesisFrancesco Ragonese, Lorenzo Monarca, Antonella De Luca, et al.
Current Pharmaceutical Design|March 17, 2020
New Insights on KCa3.1 Channel ModulationGiuseppe Manfroni, Francesco Ragonese, Lorenzo Monarca, et al.
Current Pharmaceutical Design|April 3, 2020
Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma TherapyLamberto Dionigi, Francesco Ragonese, Lorenzo Monarca, et al.
Frontiers in Physiology|January 24, 2022
LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma CellsConcetta Caglioti, Federico Palazzetti, Lorenzo Monarca, et al.
Nutrients|December 20, 2018
Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral BioavailabilityRoberto Spogli, Maria Bastianini, Francesco Ragonese, et al.
Pageof 2